SUMMARY: Long noncoding RNAs (lncRNAs) are an important class of pervasive genes, and their misregulation has been shown in various types of diseases. However, the relationship between lncRNAs and the immune response to pathogen infection has been rarely reported. Helicobacter pylori is a major human pathogenic bacterium that causes gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma, and gastric cancer. The regulatory mechanism of the H. pylori-induced immune response is not yet clear. In the present study, we identified nonoverlapping signatures of a small number of lncRNAs that were aberrantly expressed in H. pylori-infected gastric epithelial cells using microarray analysis followed by bioassays. From microarray data, we found that 23 lncRNAs were upregulated and 21 were downregulated. Five lncRNAs, XLOC_004562, XLOC_005912, XLOC_000620, XLOC_004122, and XLOC_014388, were further evaluated using quantitative reverse transcription-PCR, and the results matched well with microarray data. In addition, XLOC_004122 and XLOC_ 014388 were decreased in gastric mucosal tissues of H. pylori-positive patients. Differentially expressed lncRNAs may play a partial or key role in the immune response to H. pylori, and this may provide potential targets for the future treatment of H. pylori-related diseases.
Helicobacter pylori is the causative agent of gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma, and gastric cancer (1). A remarkable feature of H. pylori infection is that it results in the induction of a complex and fascinating immune response. During its long coexistence with humans, H. pylori, the host, and environmental factors have constituted a complex network that precisely regulates the immune response. Scientists believe that better understanding of this complex network may help to explore the diagnostic and treatment methods. Recently, certain techniques such as gene chip and microarray analysis have been used to analyze global transcriptional changes in host genes in an attempt to describe the systemic response to H. pylori and to identify novel targets or biomarkers (2, 3) .
The human transcriptome comprises not only large numbers of protein-coding messenger RNAs but also a large set of nonprotein-coding transcripts that have structural, regulatory, or unknown functions. Noncoding RNAs are divided into long noncoding RNAs (lncRNAs) and short noncoding RNAs (microRNAs, small interfering RNAs, small nucleolar RNAs, and PIWI-interacting RNAs) based on their length. lncRNAs, tentatively defined as noncoding RNAs more than 200 nt in length, are characterized by the complexity and diversity of their sequences and mechanisms of action. A few recent publications have reported that lncRNA may play important roles during cellular development, and their misregulation has also been shown in various types of disease (4). However, reports on the potential role of lncRNAs in the immune response to pathogens are rare. In this study, we identified nonoverlapping signatures of a small number of lncRNAs that were aberrantly expressed in H. pyloriinfected gastric epithelial cells using microarray analysis followed by bioassays.
The nonmalignant gastric epithelial cell line GES-1 was routinely cultured in the RPMI 1640 medium (Invitrogen, Grand Island, NY, USA) supplemented with 10z fetal bovine serum and 100 U/ml penicillin in a humidified incubator containing 5z CO 2 at 379 C. The wild-type H. pylori strain 26695 was obtained from the American Type Culture Collection (Manassas, VA, USA) and grown as previously described (5) . Subsequently, cells were seeded in a 12-well culture plate and grown to 80z confluence. Then, the medium was replaced with an antibiotic-free medium. H. pylori was added to cells at a multiplicity of infection (MOI) of 100:1. The infection model was monitored by measuring the release of interleukin 8 (IL-8) and growth-related oncogene a (GRO-a) using DuoSet ELISA Development System (R&D Systems, Minneapolis, MN, USA).
Clinical samples were obtained from a total of 57 patients in PLA 324 Hospital with H. pylori-induced chronic gastritis and 22 H. pylori-negative healthy control subjects. The H. pylori-infection status was confirmed by bacterial culture, a 13 C-urea breath test, and a histologic test. Patients were regarded as being H. pylori-positive if one of these tests yielded positive results. None of the patients received nonsteroidal antiinflammatory drugs or had taken antibiotics or proton pump inhibitors in the preceding 4 weeks. Patients with 
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H. pylori infection received a 1-week triple therapy with omeprazole, amoxicillin, and clarithromycin (20 mg, 1 g, and 500 mg, respectively), all taken twice daily for 1 week. One month after treatment was completed, the 13 C-urea breath test was conducted to detect H. pylori infection. A total of 13 patients were followed-up with endoscopy 1 year later. All the experiments were conducted according to the principles of the Helsinki Declaration. The Ethics Committee of Dalian Medical University Hospital approved the study. Total RNA was extracted from cells using TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) and then reverse transcribed using the Fermentas RT reagent kit according to the manufacturer's instructions. Levels of lncRNAs and b-actin were measured using quantitative reverse transcription (qRT)-PCR with the PrimeScript RT-PCR kits (Takara, Shiga, Japan). The sequences of primers used are shown in Table 1 . The results are expressed as means ± SD from at least 3 separate experiments performed in triplicate, and differences between groups were analyzed using the 2-tailed Student's t-test; statistical analysis was performed using SPSS software (SPSS, Armonk, NY, USA). P values of ＜0.05 were considered significant.
The RiboArray lncRNA DETECT Human Array with a coverage of 8264 unique human lncRNAs was synthesized by Ribobio (Guangzhou, China) by applying the Combimatrix platform. The procedures were performed according to the manufacturer's protocol. Briefly, 3 H. pylori-infected GES-1 samples and 3 noninfected samples were used to extract total RNA. One microgram of total RNA was reverse transcribed into aRNA, and then, 6 mg of aRNA was labeled with Cy3 fluorophore using the Amino Allyl MessageAmp TM IIaRNA Kit (Invitrogen). Microarrays with labeled samples were hybridized overnight at 409 C and washed using buffers recommended in the manufacturer's protocol. Slides were scanned using the Genepix 4000B laser scanner (Axon Instruments, Union City, CA, USA), and images were analyzed using Genepix Pro 7.0 software (Axon Instruments). Signals that were ＜1.5 times stronger than the background were removed. lncRNA microarray analysis, including labeling, hybridization, scanning, normalization, and data analysis, was performed by Ribobio. We selected lncRNAs with P-values ＜ 0.01 for further analysis.
GES-1 cells were infected with H. pylori (MOI, 100:1). Twenty-four hours later, successful infection was confirmed by the release of the proinflammatory cytokines IL-8 and GRO-a. Quantitative alterations in lncRNAs were then identified using lncRNA microarray analysis. Among lncRNAs in which alterations were idenfied, 23 lncRNAs were upregulated and 21 lncRNAs were downregulated compared with the control (Table  2) . To validate the microarray analysis findings, we selected 5 lncRNAs that were highly expressed in GES-1 cells and could be found in our coexpression network database among the differential lncRNAs and analyzed their expression using qRT-PCR. The results shown in Fig. 1A confirmed that XLOC_004562, XLOC_005912, and XLOC_000620 were highly expressed during H. pylori infection, whereas the expression of XLOC_ 004122 and XLOC_014388 was decreased (P ＜ 0.05).
Then, we analyzed the associations between lncRNAs and their clinical values in human gastric mucosal tissues. Of 57 H. pylori-positive chronic gastritis patients, 34 were males and 23 were females. Of 22 H. pylorinegative healthy control subjects, 15 were males and 7 were females, and there were no significant differences in gender, height, weight, and body mass index between the 2 groups. Histological data revealed that 49 (86.0z) H. pylori-infected patients showed evidence of inflammatory infiltrates with lymphocytes and mononuclear cells, and 15 (26.3z) showed intestinal metaplasia, whereas H. pylori-negative subjects mostly had normal mucosa. XLOC_004122 and XLOC_014388 were downregulated in H. pylori-positive patients (Fig. 1B , P ＜ 0.05), whereas no significant changes were observed in XLOC_004562, XLOC_005912, and XLOC_000620. Furthermore, among H. pylori-positive patients, we found that the expression of XLOC_004122 and XLOC _014388 was decreased in those with intestinal metaplasia ( Fig. 1C , P ＜ 0.05). It is known that H. pylori may promote the development of inflammation of the gastric mucosa, which then induces gastric atrophy and intestinal metaplasia, resulting in gastric cancer. Our study indicated that XLOC_004122 and XLOC_014388 may be closely related to this process.
We next followed-up 13 patients before and after treatment for H. pylori infection. Two patients showed no significant release of H. pylori infection and were excluded. Of the remaining 11 patients, 7 (63.6z) and 5 (45.5z) exhibited increased expression of XLOC_ 004122 and XLOC_014388, respectively, indicating that the 2 lncRNAs could be used to monitor the status of H. pylori infection.
Genetic studies have focused on noncoding RNAs for years. These abundant transcriptomes were previously regarded as``transcriptional noise''; however, over the past decade, many studies have reported that these noncoding RNAs have a series of important roles in both transcriptional and posttranscriptional regulation (6) (7) (8) . Recent publications have found that lncRNAs were involved in many regulation actions in various diseases, including breast cancer (9), colon cancer (10), prostate cancer (11), hepatocellular carcinoma (12) , and leukemia (13) . Studies have revealed the contribution of lncRNAs as protooncogenes, tumor suppressor genes, and drivers of metastatic transformation; for example, GAGE6, p15, and HOTAIR (14) (15) (16) . In particular, the lncRNA expression profile in gastric cancer has been widely studied. Lin et al. used microarray technology to characterize the role of lncRNAs in gastric cancer pathogenesis and identified 10 differentially expressed lncRNAs potentially regulating the p53 signaling pathway (17). Liu et al. found that ncRuPAR, a newly discovered lncRNA, inhibited gastric cancer progression by downregulating protease-activated receptor-1 (18). Li et al. reported that the overexpression of lncRNA H19 can enhance carcinogenesis and metastasis of gastric cancer (19) . However, there have been no reports on the expression profiles of lncRNAs in H. pylori-infected surroundings. In the current study, for the first time, we used a genome-wide microarray system to assess differences in responses of H. pylori infection in GES-1 cells and identified a small number of lncRNAs that were aberrantly expressed. Although their functions were not determined clearly, coexpression network analysis indicated that these lncRNAs were enriched for many protein-coding genes related to the immune response. For example, a total of 327 mRNAs were coexpressed with XLOC_014388, and gene ontology analysis showed that most of them participated in the regulation of cell junction and kinase activity. Among 218 mRNAs coexpressed with XLOC_004122, many were involved in the calcium signaling and Toll-like receptor pathways (data not shown). Our findings suggest that novel identified lncRNAs may play a partial or key role in the immune response to H. pylori, and this may provide potential targets for the future treatment of H. pylori-related diseases.
